|Bid||69.01 x 900|
|Ask||69.63 x 800|
|Day's Range||69.31 - 70.43|
|52 Week Range||56.56 - 73.34|
|Beta (5Y Monthly)||0.41|
|PE Ratio (TTM)||289.83|
|Earnings Date||Feb 02, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||2.84 (3.96%)|
|Ex-Dividend Date||Sep 14, 2021|
|1y Target Est||75.99|
Here's why they chose Vertex Pharmaceuticals (NASDAQ: VRTX), Gilead Sciences (NASDAQ: GILD), and Beam Therapeutics (NASDAQ: BEAM). Prosper Junior Bakiny (Vertex Pharmaceuticals): Shares of Vertex Pharmaceuticals, a biotech that focuses on developing treatments for rare diseases, have significantly lagged the market over the past year.
We’re proud to be a presenting partner of National AIDS Memorial’s World AIDS Day events. Among the activities: A virtual observance and national forum with leaders on topics related to HIV/AIDS an...
Amazon's (AMZN) AWS is chosen by Gilead Sciences as the preferred cloud provider.